179 related articles for article (PubMed ID: 8822940)
1. A new series of vitamin D analogs is highly active for clonal inhibition, differentiation, and induction of WAF1 in myeloid leukemia.
Munker R; Kobayashi T; Elstner E; Norman AW; Uskokovic M; Zhang W; Andreeff M; Koeffler HP
Blood; 1996 Sep; 88(6):2201-9. PubMed ID: 8822940
[TBL] [Abstract][Full Text] [Related]
2. 19-nor vitamin-D analogs: a new class of potent inhibitors of proliferation and inducers of differentiation of human myeloid leukemia cell lines.
Asou H; Koike M; Elstner E; Cambell M; Le J; Uskokovic MR; Kamada N; Koeffler HP
Blood; 1998 Oct; 92(7):2441-9. PubMed ID: 9746784
[TBL] [Abstract][Full Text] [Related]
3. 1,25-Dihydroxyvitamin D3 induces differentiation of a retinoic acid-resistant acute promyelocytic leukemia cell line (UF-1) associated with expression of p21(WAF1/CIP1) and p27(KIP1).
Muto A; Kizaki M; Yamato K; Kawai Y; Kamata-Matsushita M; Ueno H; Ohguchi M; Nishihara T; Koeffler HP; Ikeda Y
Blood; 1999 Apr; 93(7):2225-33. PubMed ID: 10090931
[TBL] [Abstract][Full Text] [Related]
4. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
5. 24-Oxo metabolites of vitamin D3 analogues: disassociation of their prominent antileukemic effects from their lack of calcium modulation.
Shiohara M; Uskokovic M; Hisatake J; Hisatake Y; Koike K; Komiyama A; Koeffler HP
Cancer Res; 2001 Apr; 61(8):3361-8. PubMed ID: 11309293
[TBL] [Abstract][Full Text] [Related]
6. Novel vitamin D analogs that modulate leukemic cell growth and differentiation with little effect on either intestinal calcium absorption or bone mobilization.
Zhou JY; Norman AW; Lübbert M; Collins ED; Uskokovic MR; Koeffler HP
Blood; 1989 Jul; 74(1):82-93. PubMed ID: 2665845
[TBL] [Abstract][Full Text] [Related]
7. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
Kubota T; Koshizuka K; Koike M; Uskokovic M; Miyoshi I; Koeffler HP
Cancer Res; 1998 Aug; 58(15):3370-5. PubMed ID: 9699668
[TBL] [Abstract][Full Text] [Related]
8. 1,25(OH)2-16ene-vitamin D3 is a potent antileukemic agent with low potential to cause hypercalcemia.
Jung SJ; Lee YY; Pakkala S; de Vos S; Elstner E; Norman AW; Green J; Uskokovic M; Koeffler HP
Leuk Res; 1994 Jun; 18(6):453-63. PubMed ID: 8207963
[TBL] [Abstract][Full Text] [Related]
9. Structure-function studies on analogues of 1 alpha,25-dihydroxyvitamin D3: differential effects on leukemic cell growth, differentiation, and intestinal calcium absorption.
Norman AW; Zhou JY; Henry HL; Uskokovic MR; Koeffler HP
Cancer Res; 1990 Nov; 50(21):6857-64. PubMed ID: 2208153
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of 1alpha,25(OH)2D3 and its 20-epi analog integrates clonal expansion, maturation and apoptosis during HL-60 cell differentiation.
Campbell MJ; Drayson MT; Durham J; Wallington L; Siu-Caldera ML; Reddy GS; Brown G
Mol Cell Endocrinol; 1999 Mar; 149(1-2):169-83. PubMed ID: 10375029
[TBL] [Abstract][Full Text] [Related]
11. Potent vitamin D3 analogs: their abilities to enhance transactivation and to bind to the vitamin D3 response element.
Imai Y; Pike JW; Koeffler HP
Leuk Res; 1995 Mar; 19(3):147-58. PubMed ID: 7700077
[TBL] [Abstract][Full Text] [Related]
12. 1 alpha,25-Dihydroxy-20-epi-vitamin D3: an extraordinarily potent inhibitor of leukemic cell growth in vitro.
Elstner E; Lee YY; Hashiya M; Pakkala S; Binderup L; Norman AW; Okamura WH; Koeffler HP
Blood; 1994 Sep; 84(6):1960-7. PubMed ID: 8080998
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D3 analogs: effect on leukemic clonal growth and differentiation, and on serum calcium levels.
Pakkala S; de Vos S; Elstner E; Rude RK; Uskokovic M; Binderup L; Koeffler HP
Leuk Res; 1995 Jan; 19(1):65-72. PubMed ID: 7837819
[TBL] [Abstract][Full Text] [Related]
14. Antagonistic action of novel 1alpha,25-dihydroxyvitamin D3-26, 23-lactone analogs on differentiation of human leukemia cells (HL-60) induced by 1alpha,25-dihydroxyvitamin D3.
Miura D; Manabe K; Ozono K; Saito M; Gao Q; Norman AW; Ishizuka S
J Biol Chem; 1999 Jun; 274(23):16392-9. PubMed ID: 10347199
[TBL] [Abstract][Full Text] [Related]
15. Novel analogs of 1,25-dihydroxyvitamin D
Nachliely M; Sharony E; Kutner A; Danilenko M
J Steroid Biochem Mol Biol; 2016 Nov; 164():59-65. PubMed ID: 26365556
[TBL] [Abstract][Full Text] [Related]
16. Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3.
Boehm MF; Fitzgerald P; Zou A; Elgort MG; Bischoff ED; Mere L; Mais DE; Bissonnette RP; Heyman RA; Nadzan AM; Reichman M; Allegretto EA
Chem Biol; 1999 May; 6(5):265-75. PubMed ID: 10322128
[TBL] [Abstract][Full Text] [Related]
17. 1,25-Dihydroxyvitamin D3: in vivo and in vitro effects on human preleukemic and leukemic cells.
Koeffler HP; Hirji K; Itri L
Cancer Treat Rep; 1985 Dec; 69(12):1399-407. PubMed ID: 2416438
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D3 analogs and their 24-oxo metabolites equally inhibit clonal proliferation of a variety of cancer cells but have differing molecular effects.
Campbell MJ; Reddy GS; Koeffler HP
J Cell Biochem; 1997 Sep; 66(3):413-25. PubMed ID: 9257197
[TBL] [Abstract][Full Text] [Related]
19. Biological activity of fluorinated vitamin D analogs at C-26 and C-27 on human promyelocytic leukemia cells, HL-60.
Inaba M; Okuno S; Nishizawa Y; Yukioka K; Otani S; Matsui-Yuasa I; Morisawa S; DeLuca HF; Morii H
Arch Biochem Biophys; 1987 Nov; 258(2):421-5. PubMed ID: 2823715
[TBL] [Abstract][Full Text] [Related]
20. Effects of analogs of 1,25(OH)2 vitamin D3 on the proliferation and differentiation of the human chronic myelogenous leukemia cell line, RWLeu-4.
Clark JW; Posner MR; Marsella JM; Santos A; Uskokovic M; Eil C; Lasky SR
J Cancer Res Clin Oncol; 1992; 118(3):190-4. PubMed ID: 1372318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
